A dose-ranging study of behavioral and pharmacological treatment in social settings for children with ADHD

William E. Pelham, Lisa Burrows-Maclean, Elizabeth M. Gnagy, Gregory A. Fabiano, Erika K. Coles, Brian T. Wymbs, Anil Chacko, Kathryn S. Walker, Frances Wymbs, Allison Garefino, Martin T. Hoffman, James Waxmonsky, Daniel Waschbusch

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Placebo and three doses of methylphenidate (MPH) were crossed with 3 levels of behavioral modification (no behavioral modification, NBM; low-intensity behavioral modification, LBM; and high-intensity behavior modification, HBM) in the context of a summer treatment program (STP). Participants were 48 children with ADHD, aged 5-12. Behavior was examined in a variety of social settings (sports activities, art class, lunch) that are typical of elementary school, neighborhood, and after-school settings. Children received each behavioral condition for 3 weeks, order counterbalanced across groups. Children concurrently received in random order placebo, 0.15 mg/kg/dose, 0.3 mg/kg/dose, or 0.6 mg/kg/dose MPH, 3 times daily with dose manipulated on a daily basis in random order for each child. Both behavioral and medication treatments produced highly significant and positive effects on children's behavior. The treatment modalities also interacted significantly. Whereas there was a linear dose-response curve for medication in NBM, the dose-response curves flattened considerably in LBM and HBM. Behavior modification produced effects as large as moderate doses, and on some measures, high doses of medication. These results replicate and extend to social-recreational settings previously reported results in a classroom setting from the same sample (Fabiano et al., School Psychology Review, 36, 195-216, 2007). Results illustrate the importance of taking dosage/intensity into account when evaluating combined treatments; there were no benefits of combined treatments when the dosage of either treatment was high but combination of the low-dose treatments produced substantial incremental improvement over unimodal treatment.

Original languageEnglish (US)
Pages (from-to)1019-1031
Number of pages13
JournalJournal of Abnormal Child Psychology
Volume42
Issue number6
DOIs
StatePublished - Jan 1 2014

Fingerprint

Pharmacology
Methylphenidate
Behavior Therapy
Therapeutics
Placebos
Lunch
Child Behavior
Art
Sports
Psychology

All Science Journal Classification (ASJC) codes

  • Developmental and Educational Psychology
  • Psychiatry and Mental health

Cite this

Pelham, William E. ; Burrows-Maclean, Lisa ; Gnagy, Elizabeth M. ; Fabiano, Gregory A. ; Coles, Erika K. ; Wymbs, Brian T. ; Chacko, Anil ; Walker, Kathryn S. ; Wymbs, Frances ; Garefino, Allison ; Hoffman, Martin T. ; Waxmonsky, James ; Waschbusch, Daniel. / A dose-ranging study of behavioral and pharmacological treatment in social settings for children with ADHD. In: Journal of Abnormal Child Psychology. 2014 ; Vol. 42, No. 6. pp. 1019-1031.
@article{12aea68fcc554aec9d2380fb7b63b8fd,
title = "A dose-ranging study of behavioral and pharmacological treatment in social settings for children with ADHD",
abstract = "Placebo and three doses of methylphenidate (MPH) were crossed with 3 levels of behavioral modification (no behavioral modification, NBM; low-intensity behavioral modification, LBM; and high-intensity behavior modification, HBM) in the context of a summer treatment program (STP). Participants were 48 children with ADHD, aged 5-12. Behavior was examined in a variety of social settings (sports activities, art class, lunch) that are typical of elementary school, neighborhood, and after-school settings. Children received each behavioral condition for 3 weeks, order counterbalanced across groups. Children concurrently received in random order placebo, 0.15 mg/kg/dose, 0.3 mg/kg/dose, or 0.6 mg/kg/dose MPH, 3 times daily with dose manipulated on a daily basis in random order for each child. Both behavioral and medication treatments produced highly significant and positive effects on children's behavior. The treatment modalities also interacted significantly. Whereas there was a linear dose-response curve for medication in NBM, the dose-response curves flattened considerably in LBM and HBM. Behavior modification produced effects as large as moderate doses, and on some measures, high doses of medication. These results replicate and extend to social-recreational settings previously reported results in a classroom setting from the same sample (Fabiano et al., School Psychology Review, 36, 195-216, 2007). Results illustrate the importance of taking dosage/intensity into account when evaluating combined treatments; there were no benefits of combined treatments when the dosage of either treatment was high but combination of the low-dose treatments produced substantial incremental improvement over unimodal treatment.",
author = "Pelham, {William E.} and Lisa Burrows-Maclean and Gnagy, {Elizabeth M.} and Fabiano, {Gregory A.} and Coles, {Erika K.} and Wymbs, {Brian T.} and Anil Chacko and Walker, {Kathryn S.} and Frances Wymbs and Allison Garefino and Hoffman, {Martin T.} and James Waxmonsky and Daniel Waschbusch",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/s10802-013-9843-8",
language = "English (US)",
volume = "42",
pages = "1019--1031",
journal = "Journal of Abnormal Child Psychology",
issn = "0091-0627",
publisher = "Springer New York",
number = "6",

}

Pelham, WE, Burrows-Maclean, L, Gnagy, EM, Fabiano, GA, Coles, EK, Wymbs, BT, Chacko, A, Walker, KS, Wymbs, F, Garefino, A, Hoffman, MT, Waxmonsky, J & Waschbusch, D 2014, 'A dose-ranging study of behavioral and pharmacological treatment in social settings for children with ADHD', Journal of Abnormal Child Psychology, vol. 42, no. 6, pp. 1019-1031. https://doi.org/10.1007/s10802-013-9843-8

A dose-ranging study of behavioral and pharmacological treatment in social settings for children with ADHD. / Pelham, William E.; Burrows-Maclean, Lisa; Gnagy, Elizabeth M.; Fabiano, Gregory A.; Coles, Erika K.; Wymbs, Brian T.; Chacko, Anil; Walker, Kathryn S.; Wymbs, Frances; Garefino, Allison; Hoffman, Martin T.; Waxmonsky, James; Waschbusch, Daniel.

In: Journal of Abnormal Child Psychology, Vol. 42, No. 6, 01.01.2014, p. 1019-1031.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A dose-ranging study of behavioral and pharmacological treatment in social settings for children with ADHD

AU - Pelham, William E.

AU - Burrows-Maclean, Lisa

AU - Gnagy, Elizabeth M.

AU - Fabiano, Gregory A.

AU - Coles, Erika K.

AU - Wymbs, Brian T.

AU - Chacko, Anil

AU - Walker, Kathryn S.

AU - Wymbs, Frances

AU - Garefino, Allison

AU - Hoffman, Martin T.

AU - Waxmonsky, James

AU - Waschbusch, Daniel

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Placebo and three doses of methylphenidate (MPH) were crossed with 3 levels of behavioral modification (no behavioral modification, NBM; low-intensity behavioral modification, LBM; and high-intensity behavior modification, HBM) in the context of a summer treatment program (STP). Participants were 48 children with ADHD, aged 5-12. Behavior was examined in a variety of social settings (sports activities, art class, lunch) that are typical of elementary school, neighborhood, and after-school settings. Children received each behavioral condition for 3 weeks, order counterbalanced across groups. Children concurrently received in random order placebo, 0.15 mg/kg/dose, 0.3 mg/kg/dose, or 0.6 mg/kg/dose MPH, 3 times daily with dose manipulated on a daily basis in random order for each child. Both behavioral and medication treatments produced highly significant and positive effects on children's behavior. The treatment modalities also interacted significantly. Whereas there was a linear dose-response curve for medication in NBM, the dose-response curves flattened considerably in LBM and HBM. Behavior modification produced effects as large as moderate doses, and on some measures, high doses of medication. These results replicate and extend to social-recreational settings previously reported results in a classroom setting from the same sample (Fabiano et al., School Psychology Review, 36, 195-216, 2007). Results illustrate the importance of taking dosage/intensity into account when evaluating combined treatments; there were no benefits of combined treatments when the dosage of either treatment was high but combination of the low-dose treatments produced substantial incremental improvement over unimodal treatment.

AB - Placebo and three doses of methylphenidate (MPH) were crossed with 3 levels of behavioral modification (no behavioral modification, NBM; low-intensity behavioral modification, LBM; and high-intensity behavior modification, HBM) in the context of a summer treatment program (STP). Participants were 48 children with ADHD, aged 5-12. Behavior was examined in a variety of social settings (sports activities, art class, lunch) that are typical of elementary school, neighborhood, and after-school settings. Children received each behavioral condition for 3 weeks, order counterbalanced across groups. Children concurrently received in random order placebo, 0.15 mg/kg/dose, 0.3 mg/kg/dose, or 0.6 mg/kg/dose MPH, 3 times daily with dose manipulated on a daily basis in random order for each child. Both behavioral and medication treatments produced highly significant and positive effects on children's behavior. The treatment modalities also interacted significantly. Whereas there was a linear dose-response curve for medication in NBM, the dose-response curves flattened considerably in LBM and HBM. Behavior modification produced effects as large as moderate doses, and on some measures, high doses of medication. These results replicate and extend to social-recreational settings previously reported results in a classroom setting from the same sample (Fabiano et al., School Psychology Review, 36, 195-216, 2007). Results illustrate the importance of taking dosage/intensity into account when evaluating combined treatments; there were no benefits of combined treatments when the dosage of either treatment was high but combination of the low-dose treatments produced substantial incremental improvement over unimodal treatment.

UR - http://www.scopus.com/inward/record.url?scp=84904168167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904168167&partnerID=8YFLogxK

U2 - 10.1007/s10802-013-9843-8

DO - 10.1007/s10802-013-9843-8

M3 - Article

VL - 42

SP - 1019

EP - 1031

JO - Journal of Abnormal Child Psychology

JF - Journal of Abnormal Child Psychology

SN - 0091-0627

IS - 6

ER -